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ECM and Cell Surface Proteolysis: Minireview
Regulating Cellular Ecology
Zena Werb mechanism could explain how the shedding of L-selec-
tin and syndecan can occur within minutes upon cellDepartment of Anatomy
University of California, San Francisco stimulation. Through these diverse mechanisms, adhe-
sion, deadhesion, and ECM proteolysis are all broughtSan Francisco, California 94143-0750
to bear at the leading edge of migrating and invading
cells where dynamic changes take place.
However, the ECM, per se, is not the only target ofCell±cell and cell±extracellular matrix (ECM) interactions
pericellular proteolysis (Table 1). During the cellularprovide cells with information essential for controlling
response to developmental and pathologic cues, cellmorphogenesis, cell fate specification, gain or loss of
surface proteins, receptors, and transmembrane ECMtissue-specific functions, cell migration, tissue repair,
proteins are altered by proteolysis. The nature of theand cell death. Degradation or activation of cell surface
proteinases mediating these events has been elusive,and ECM proteins by proteolysis can mediate rapid and
but there are now emerging concepts supporting a roleirreversible responses to changes in the cellular micro-
for integral membrane proteinases. The ADAMs (Wolfs-environment. By concentrating proteolytic events at or
berg and White, 1996; Blobel, 1997) are particularly in-near the cell surface, these processes can be effective
even in thepresence of high concentrations of inhibitors. triguing because they contain both cell adhesion and
proteolytic domains. Kuz, the Drosophila homolog ofThis minireview considers the cellular and organismal
functions of ECM proteinases. Their biochemical and ADAM 10, activates the signaling receptor Notch during
development and TNFa converting enzyme (TACE) re-structural properties are reviewed elsewhere (Stocker
et al., 1995; Wolfsberg and White, 1996; Andreasen et leases membrane-bound TNFa by proteolysis.
Genetic Dissection of ECM Proteolysis In Vivoal., 1997; Sternlicht and Werb, 1997).
ECM Proteolysis in the Pericellular Environment Genetic modification of proteinase and inhibitor gene
expression in vivo is necessary to elucidate their realProteolysis regulates ECM assembly, editing of excess
ECM components, remodeling of ECM structure, and functions (Coussens and Werb, 1996; Andreasen et al.,
1997; Shapiro, 1997). The initial studies of null mutantsrelease of bioactive fragments and growth factors during
growth, morphogenesis, tissue repair, and pathological of uPA, tPA, MMPs, and their inhibitors PAI-1 and
TIMP-1 were disappointing because of their mild pheno-processes. The major enzymes that degrade ECM and
cell surface proteins (Table 1) are the matrix metallo- types. In contrast, their ectopic expression produces
pathologic remodeling. This suggests that requirementsproteinase (MMP) family of secreted and membrane
proteinases, the adamalysin-related membrane protein- for pericellular proteolysis become evident only under
conditions of acute perturbation. What is less obviousases that contain disintegrin and metalloproteinase
domains (ADAMs or MDCs), the bone morphogenetic is why lack of specific proteinases produces so few
defects during development. Perhaps, under conditionsprotein 1 (BMP1)/tolloid (tld) family of metalloprotein-
ases, and tissue serine proteinases, such as thrombin, of rapid growth with the abundant synthesis of new ECM
molecules, the degradation of a much smaller amounttissue plasminogen activator (tPA), urokinase (uPA), and
plasmin. of ECM left behind during migration or branching is
irrelevant.ECM degradation in vivo is confined to the immediate
pericellular environment of cells. Antibodies that recog- However, deficient proteolysis leads to disease pro-
cesses, just as overproduction of proteinases does. Innize neoepitopes created by proteolytic cleavage show
staining concentrated around cells, even when the pro- vivo, degradation of the provisional ECM produced by
wounding is a key step in the healing process. Once theteinase is soluble. But how can the proteinases be used
in a spatially confined manner? The proteolytic events fibrin clot has formed, migrating keratinocytes, which
produce MMPs and uPA, close the wound surface andare exquisitely regulated and confined by localizing the
enzymes to receptors, adhesion sites, or invasive protru- interact with the underlying dermal fibroblasts to repair
the injury. In mice that have a targeted null mutation insions of cells where ECM degradation takes place (An-
dreasen et al., 1997; Nakahara et al., 1997, and refer- their plasminogen gene, keratinocytes at the wound
edge do not degrade fibrin and are incapable of migrat-ences therein). Several distinct mechanisms are used
to target proteinases to specific membrane domains. A ing, and the wound does not heal (Bugge et al.,1996, and
references therein). Keratinocyte behavior is particularlysequence in the transmembrane/cytoplasmic domain of
MT1-MMP targets it to invasive sites. Not only is MT1- sensitive to ECM fragments produced by proteolysis.
Cleavage of epithelial laminin-5 by gelatinase A inducesMMP an ECM-degrading proteinase in its own right, but,
in a complex with the tissue inhibitor of metalloprotein- keratinocyte migration (Giannelli et al., 1997), whereas
keratinocytes are unable to migrate on collagen type Iases (TIMP)-2, it is also an activator and receptor for
gelatinase A (Figure 1). A different strategy is used to that hasbeen rendered resistant to proteolysis by mutat-
ing the collagenase cleavage site (Pilcher et al., 1997).confine uPA to the uPA receptor (uPA-R) at the invasive
edge of migrating cells. uPA-R is itself an adhesion Moreover, a decrease in stromelysin-1 expression ow-
ing to a promoter polymorphism is associated with in-receptor for vitronectin, but also interacts laterally with
integrin b chains. Regulating the localization of mem- creased progression of a common human disease, ath-
erosclerosis (Ye et al., 1996). These studies support thebrane-bound proteinases to membrane domains proxi-
mal to their substrates by interactions with the cyto- need for pericellular proteolysis in migration and remod-
eling.skeleton would modulate proteolysis rapidly. Such a
Cell
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Table 1. ECM and Cell Surface Substrates of Pericellular
Proteinases
Enzymes Other Names Substratesa
MMPs
MMP-1 collagenase-1 Col I, II, III, VII, X, GL, EN, LP,
MMP-8 collagenase-2 AG, TN, L-selectin, IGF-BP,
MMP-13 collagenase-3 Pro-MMP-2, -9, a2M, a1PI
MMP-2 gelatinase A GL, Col I, IV, V, VII, X, XI, EL,
MMP-9 gelatinase B FN, LN, LP, AG, galectin-3,
IGF-BP, VN, FGF receptor-1,
Figure 1. Cell Surface Activation of Progelatinase A by MT1-MMPPro-MMP-2, -9, -13
The zymogen (pro)form of the transmembrane MT1-MMP is acti-MMP-3 stromelysin-1 PG, LN, FN, GL, Col III, IV,
vated by proteolysis, either in the Golgi by a furin family proteinaseMMP-10 stromelysin-2 V, IX, X, XI, LP, FB, EN, TN, VN,
or on the cell surface by a proteinasesuch as plasmin. The activatedMMP-7 matrilysin Pro-MMP-1, -8, -9, -13, a1PI,
MT1-MMP then binds the inhibitor TIMP-2 by its N-terminal inhibi-
a2M, L-selectin
tory domain. The C-terminal domain of the bound TIMP-2 then acts
MMP-12 metalloelastase EL, FB, FN, LN, PG, MBP, as a receptor for binding the C-terminal hemopexin domain of pro-
PL, a1PI gelatinase A (proGelA). A second molecule of MT1-MMP cleaves
and activates the bound progelatinase A to give active gelatinaseMMP-14 MT1-MMP Col I, II, III, GL, FN, LN, VN,
A that can remain membrane-bound or be released.MMP-15 MT2-MMP PG, Pro-MMP-2, -13, a1PI,
a2M
MMP-11 stromelysin-3 LN, FN, AG, a1PI, a2M
for altering anchorage in vivo. Controlling apoptosis by
Other Proteinases
regulating ECM proteolysis is likely to be widespread inuPA PL, FN, HGF
epithelial tissues, which require adhesion for survival. IttPA
may be the loss of responsiveness to this feature of
Plasmin FB, FN, TN, LN, AG, latent
ECM signaling that underlies immortalization, the first,TGFb BP, PG, Pro-MMP-1,
critical step toward neoplasia.-3, -9, -14, C1, C3, C5
In the mammary gland, ECM is remodeled during the
Thrombin FB, Pro-MMP-2, syndecan
differentiation cycle of pregnancy, lactation, and involu-
BMP-1 tld (procollagen proCOL I, LN-5, latent tion (Coussens and Werb, 1996). Proteinases mediate
C-peptidase) TGFb family
ECM degradation, in parallel with apoptosis during invo-
Kuzbanian ADAM 10 (Kuz) Notch, cell-bound TNFa, MBP lution after lactation. Ectopic expression of stromelysin-1
TACE ADAM 17 cell bound TNFa induces unscheduled entactin degradation and mam-
mary involution, whereas its inhibition delays apoptosis.Abbreviations: aggrecan,AG; a1-proteinase inhibitor,a1PI; a2-mac-
What is particularly fascinating is that the same MMProglobulin, a2M; binding protein, BP; collagen type, Col; comple-
that induces apoptosis during pregnancy, stimulatesment, C; elastin, EL; entactin, EN; fibrin/fibrinogen, FB; fibronectin,
FN; gelatins, GL; hepatocyte growth factor, HGF; laminin, LN; link ductal branching morphogenesis during puberty. Speci-
protein, LP; myelin basic protein, MBP; plasminogen, PL; proteo- ficity may come from using different ECM targets or
glycans, PG; tenascin, TN; vitronectin, VN; gelatinase A, 72 kDa receptors at different times in development.
gelatinase; gelatinase B, 92 kDa gelatinase.
Programmed cell death also regulates neuronal com-a Substrates are grouped for similar enzymes, but not all of the
munication, both during development and in diseaseproteins in each group are cleaved by all the enzymes in the group.
processes. In the hippocampus tPA participates in neu-
ronal plasticity. Plasmin generated by tPA induces neu-
ronal cell death (Tsirka et al., 1997, and referencesThe enzymes that cleave the N- and C-terminal pro-
peptides of the fibrillar collagens during collagenassem- therein), probably through degradation of ECM mole-
cules that are essential for neuronal survival in culture.bly have long been sought. The surprising discovery
that BMP1 cleaves the C-terminal propeptide of type I The excitotoxin-stimulated neurons no longer die in ani-
mals null for tPA.collagen supports the original finding that a metallo-
enzyme is involved. BMP1, which was isolated as an Interestingly, in both mammary gland and brain, the
proteinases are expressed by the supporting cells (stro-inducer of bone formation, is related to tld, which acti-
vates decapentaplegic, a member of the TGFb super- mal or microglial), not by the epithelial or neuronal cells
that die. Thus, apoptosis is an example of cell-to-cellfamily that specifies the dorsal±ventral axis in Drosoph-
ila. Mouse embryos with homozygous deletions in the communication, with ECM proteinases as the media-
tors. However, the cleavage of ECM components canBMP1/tld gene develop until late gestation with few mor-
phologic defects, but have abnormal collagen fibrils and also enhance viability of cells by the generation of bioac-
tive fragments of ECM proteins or release of cytokines.die at birth (Suzuki et al., 1996, and references therein).
However, mutations in tld in Drosophila have severe In the case for melanoma cells, degradation of collagen
promotes survival by liberating fragments recognizeddevelopmental consequences. This opens up the possi-
bility that ECM proteinases important in mammalian em- by avb3 integrin (Varner and Cheresh, 1996).
ECM Proteolysis and Neoplastic Transformationbryogenesis still remain to be discovered.
ECM Proteolysis and Regulation of Apoptosis ECM-degrading MMPs, uPA, and other proteinases are
universally expressed during tumor progression andECM providesadhesive signals that control cell viability.
Degradation of ECM is the most effective mechanism metastasis (Coussens and Werb, 1996; Andreasen et
Minireview
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Figure 2. ECM Proteinases Act in Signaling
Pathways
Plasma membrane (PM) receptors of the PAR
family are cleaved by ECM proteinases
(P'ASE), such as thrombin or tryptase, to re-
lease a blocking peptide, allowing the internal
ligand to bind and activate a G protein±
coupled signaling cascade. When the GPI-
anchored uPA-R binds uPA, it interacts later-
ally with integrins and binds caveolin that
could activate signaling pathways mediated
by Grb2. Receptor-bound uPA is also active
in proteolysis. The transmembrane ADAM
proteinases cleave plasma membrane target
substrates such as receptors. Kuz activates
Notch for adhesion and signal transduction
by proteolysis in cis. Degradation of cell ad-
hesion molecules, such as cadherins or syn-
decans by ECM proteinases, releases their
linkage with the cytoskeleton and alters sig-
naling. Proteolysis of ECM proteins alters in-
tegrin-mediated anchorage, focal adhesions,
cytoskeletal architecture, and signaling molecules like FAK. Binding of cleaved ECM fragments by integrins also activates different pathways
than binding of intact molecules. Proteolysis can activate growth factors, such as TGFb, by liberating them from binding proteins in ECM.
The growth factors then can bind to and activate their plasma membrane receptors, and initiate the downstream signaling cascades.
al., 1997). The majority of proteinases are made by the L-selectin, the apoptosis inducer Fas ligand, TGFa, and
the IL-6 receptor, is mediated by enzymes that mayresponding stroma of epithelial tumors. The enzymes
be distinct from TACE. ECM proteinases may be ascan then bind to the surface of tumor cells. Whether or
important as regulators of cytokine function, epithelialhow these proteinases are involved in angiogenesis,
barrier function, or antimicrobial activity, as they are intumor initiation, growth, metastasis, or in the host de-
ECM proteolysis.fense against the tumor remains to be determined.
Extracellular Proteolysis and Signal TransductionMost commonly, proteinases facilitate tumor progres-
During cellular responses to developmental and patho-sion. Proteinases may act on ECM to free cells from
logic cues, ECM, cell surface proteins, and receptorsECM-induced cell cycle arrest, facilitate dedifferentia-
are activated or removed by proteolysis. Just as proteintion, mediate invasion, or release latent growth/angio-
modification by phosphorylation is an effective meansgenesis factors (Coussens and Werb, 1996). Blocking
of intracellular signal transduction, protein modificationfunction of ECMproteinases can decrease tumor growth
by proteolysis, by virtue of its irreversible nature, is ide-(Martin et al., 1997; Wilson et al., 1997), while their ec-
ally suited to regulate extracellular signal transductiontopic expression can increase carcinogenic potential,
in the pericellular environment and thus to push forwardindicating that they contribute to the neoplasticprocess.
the unidirectional decisions of development and diseaseHowever, proteinases also may inhibit tumorigenesis by
(Figure 2).inducing apoptosis or by releasing latent angiogenesis
The prototype for such signaling is the protease-acti-inhibitors from ECM proteins.
vated receptor (PAR) family, which encode blocked,Pericellular Proteolysis and Immunity
tethered ligands (Ishihara et al., 1997, and referencesOne overlooked aspect of pericellular proteolysis is its
therein). Thrombin cleaves PAR-1 or PAR-3, initiating apotential role in immunity and host defense. ECM pro-
G protein±coupled cascade that can regulate fibroblast
teolytic cascadesresemble those of complement activa-
proliferation or neuronal survival. PAR-2 activation by
tion and coagulation, and macrophages and other in-
tryptase released by mast cells may underlie increased
flammatory cells involved in the innate immune response collagen I synthesis by fibroblasts (Cairns and Walls,
express many ECM proteinases (Andreasen et al., 1997; 1997, and references therein) seen in fibrosis, inflamma-
Shapiro, 1997). That extracellular proteinases regulate tion, and neoplastic progression. The binding of uPA to
host defense through effects on migration or processing uPA-R is a distinct paradigm. uPA induces interaction
of cytokines, complement, or fibrin, is suggested by de- of uPA-R with b1 and b2 integrins, thereby regulating
creased response of macrophagesto inflammatorystimuli adhesion and signaling. Although bound uPA is active,
in metalloelastase-deficient mice and increased sus- its activity is not required for signaling (Andreasen et
ceptibility of uPA-deficient mice to infection. Moreover, al., 1997). Whether similar signaling takes place for other
matrilysin, which is secreted luminally in epithelia, is interactions of MMPs or ADAMs with their receptors
critically placed to activate the antimicrobial cryptidins. remains to be determined.
TNFa, a potent mediator of inflammation, is synthe- ADAMs, which can process or remove the extracellu-
sized as a transmembrane molecule that can bind to lar domains of cell surface proteins, are critically placed
its receptor by cell±cell contact. It is processed by pro- for regulating signaling (Blobel, 1997). Indeed, Kuz pro-
teolysis to a soluble homotrimer by TACE (Blobel, cesses Notch so that it is competent for signaling in
1997). Shedding of other cell surface molecules involved development. It is intriguing that the extracellular do-
main of Notch 4 is deleted in the constitutively active,in innate immunity, including the adhesion molecule
Cell
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Pilcher, B.K., Dumin, J.A., Sudbeck, B.D., Krane, S.M., Welgus, H.G.,oncogenic form that induces breast cancer. Proteolysis
and Parks, W.C. (1997). J. Cell Biol. 137, 1445±1457.of extracellular domains of tumor suppressors, such as
Shapiro, S.D. (1997). Matrix Biol. 15, 527±533.Notch 4, E-cadherin, syndecan, or DCC (deleted in colon
Sternlicht, M., and Werb, Z. (1997). In Guidebook to the Extracellularcarcinoma), would alter their signaling functions pheno-
Matrix and Adhesion Proteins, 2nd Ed., T. Kreis and R. Vale, eds.typically. Such ECM proteinases could have major con-
(Oxford: Oxford University Press), in press.
sequences for tumorigenesis.
Stocker, W., Grams, F., Baumann, U., Reinemer, P., Gomis-Ruth,Proteolysis also releases cryptic activities of ECM li-
F.-X., McKay, D.B., and Bode, W. (1995). Protein Sci. 4, 823±840.
gands that may signal differently than the intact protein.
Suzuki, N., Labosky, P.A., Furuta, Y., Hargett, L., Dunn, R., Fogo,
Once cleaved, ECM fragments may bind different inte- A.B., Takahara, K., Petero, D.M., Greenspan, D.S., and Hogan, B.L.
grins; e.g., avb3 for cleaved collagen, versus a1b2 for (1996). Development 122, 3587±3589.
intact collagen. Engaging only the central cell-binding Tsirka, S.E., Rogove, A.D., Bugge, T.H., Degen, J.L., and Strickland,
domain of fibronectin activates AP-1, while whole fibro- S. (1997). J. Neurosci. 17, 543±552.
nectin does not, and cleaved laminin-5 activates differ- Varner, J.A., and Cheresh, D.A. (1996). Curr. Opin. Cell Biol. 8,
724±730.ent pathways than the intact molecule (Giannelli et al.,
1997, and references therein). Wilson, C.L., Heppner, K.J., Labosky, P.A., Hogan, B.L., and Matri-
sian, L.M. (1997). Proc. Natl. Acad. Sci. USA 94, 1402±1407.Sequestration, presentation, or activation of growth
Wolfsberg, T.G., and White, J.M. (1996). Dev. Biol. 180, 389±401.factors is also regulated by proteolysis. Latent TGFb-
and IGF-binding proteins are ECM proteins that can be Ye, E., Eriksson, P., Hamsten, A., Kurkinen, M., Humphries, S.E.,
and Henney, A.M. (1996). J. Biol. Chem. 271, 13055±13060.degraded by proteinases, releasing the growth factors.
BMP1/tld may activate TGFb family proteins by cleaving
latency proteins, whereas uPA cleaves the HGF precur-
sor to its active form. In contrast, with degradation of
heparan sulfate proteoglycans, which are coreceptors
for FGF, Wnt, and VEGF family members, the sequestra-
tion of growth factors next to their receptors is lost and
growth factor signaling is compromised (Andreasen et
al., 1997; Kispert et al., 1996, and references therein).
Conclusions
Our understanding of proteolysis of ECM and cell sur-
face molecules has expanded dramatically. We now
know that the most significant proteolytic events are
confined to the pericellular environment. With the dis-
covery of new proteinases with new functions come new
avenues for exploration in areas of development and
disease. The synergy between adhesion, ECM, and pro-
teolysis has been advanced by discovery of the intimate
relationships between proteinases and signal transduc-
tion, particularly as effectors of epithelial±stromal inter-
actions. Understanding the mechanisms by which peri-
cellular proteinases are regulated and activated, the
nature of their molecular targets, and how adhesion and
proteolysis are integrated will provide exciting avenues
for investigation over the next few years.
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